These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

466 related items for PubMed ID: 32298485

  • 1. Programmed cell death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expression in PD-1 inhibitor-associated colitis and its mimics.
    Cassol CA, Owen D, Kendra K, Braga JR, Frankel WL, Arnold CA.
    Histopathology; 2020 Aug; 77(2):240-249. PubMed ID: 32298485
    [Abstract] [Full Text] [Related]

  • 2. Variable Expression of Programmed Cell Death Protein 1-Ligand 1 in Kidneys Independent of Immune Checkpoint Inhibition.
    Hakroush S, Kopp SB, Tampe D, Gersmann AK, Korsten P, Zeisberg M, Tampe B.
    Front Immunol; 2020 Aug; 11():624547. PubMed ID: 33552089
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Differential risks of immune-related colitis among various immune checkpoint inhibitor regimens.
    Yao J, Li M, Zhang H, Ge Y, Weygant N, An G.
    Int Immunopharmacol; 2020 Oct; 87():106770. PubMed ID: 32702598
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Switching administration of anti-PD-1 and anti-PD-L1 antibodies as immune checkpoint inhibitor rechallenge in individuals with advanced non-small cell lung cancer: Case series and literature review.
    Kitagawa S, Hakozaki T, Kitadai R, Hosomi Y.
    Thorac Cancer; 2020 Jul; 11(7):1927-1933. PubMed ID: 32421224
    [Abstract] [Full Text] [Related]

  • 11. Bifidobacterium infantis Induces Protective Colonic PD-L1 and Foxp3 Regulatory T Cells in an Acute Murine Experimental Model of Inflammatory Bowel Disease.
    Zhou L, Liu D, Xie Y, Yao X, Li Y.
    Gut Liver; 2019 Mar 15; 13(4):430-439. PubMed ID: 30600673
    [Abstract] [Full Text] [Related]

  • 12. Checkpoint inhibitor colitis: a new model of inflammatory bowel disease?
    Siakavellas SI, Bamias G.
    Curr Opin Gastroenterol; 2018 Nov 15; 34(6):377-383. PubMed ID: 30157044
    [Abstract] [Full Text] [Related]

  • 13. PD1/PD-L1 Expressions in Plasmablastic Lymphoma with Clinicopathological Correlation.
    Rosado FG, Coberly J, Gupta A, John G, Naina H, Koduru P, Chen W.
    Ann Clin Lab Sci; 2021 Mar 15; 51(2):174-181. PubMed ID: 33941556
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Cardiotoxicity of Anti-PD-L1 Antibody and the Effect of Levothyroxine 
in Attenuating the Related Mortality in Mice].
    Chen Z, Wang M, Gao S, Guo H, Wang G, Zhou G.
    Zhongguo Fei Ai Za Zhi; 2021 Jun 20; 24(6):394-403. PubMed ID: 34157799
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of programmed death ligand 1 in refractory inflammatory bowel disease.
    Nguyen J, Finkelman BS, Escobar D, Xue Y, Wolniak K, Pezhouh M.
    Hum Pathol; 2022 Aug 20; 126():19-27. PubMed ID: 35489437
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The Triple Positivity for EBV, PD-1, and PD-L1 Identifies a Very High Risk Classical Hodgkin Lymphoma.
    Ozturk V, Yikilmaz AS, Kilicarslan A, Bakanay SM, Akinci S, Dilek İ.
    Clin Lymphoma Myeloma Leuk; 2020 Jul 20; 20(7):e375-e381. PubMed ID: 32295735
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.